Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Desmopressin vs Oral Bisoprolol in FESS
NCT05430048Phase 2Completed
- Sponsor
- Zagazig University
- Start
- Jul 2022
- Primary completion
- Oct 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of desmopressin in chronic rhinosinusitis (CRS), nasal polyps, sponsored by Zagazig University. Started Jul 2022; status: completed.
02
Drugs
desmopressin
03
Conditions
chronic rhinosinusitis (CRS)nasal polyps
Beyond the preview
Go deeper on NCT05430048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05430048.